Testing effectiveness (Phase 2)UnknownNCT05659186
What this trial is testing
PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
Who this might be right for
Thyroid Cancer
West China Hospital 20